Ultragenyx Pharmaceutical Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 92.3M shares, a 27.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 92.3M +20.1M +27.9% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 92.1M +20.7M +28.9% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 83.1M +12.4M +17.6% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 82.3M +12.1M +17.3% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 72.2M +2.09M +2.99% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 71.5M +1.46M +2.08% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 70.7M +863K +1.24% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 70.2M +852K +1.23% Dec 31, 2022 10-K 2024-02-21
Q3 2022 70.1M +2.12M +3.12% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 70M +2.25M +3.31% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 69.8M +2.36M +3.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 69.3M +2.53M +3.78% Dec 31, 2021 10-K 2023-02-17
Q3 2021 68M +7.15M +11.8% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 67.8M +7.35M +12.2% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 67.4M +7.95M +13.4% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 66.8M +8.98M +15.5% Dec 31, 2020 10-K 2022-02-15
Q3 2020 60.8M +3.07M +5.31% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 60.4M +2.75M +4.77% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 59.5M +2.18M +3.81% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 57.8M +6.98M +13.7% Dec 31, 2019 10-K 2021-02-12
Q3 2019 57.7M +7.22M +14.3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 57.7M +7.55M +15.1% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 57.3M +7.64M +15.4% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 50.9M +6.69M +15.2% Dec 31, 2018 10-K 2020-02-14
Q3 2018 50.5M +8.04M +18.9% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 50.1M +7.69M +18.1% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 49.7M +7.39M +17.5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 44.2M +2.93M +7.1% Dec 31, 2017 10-K 2019-02-20
Q3 2017 42.5M +2.44M +6.08% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 42.4M +3.38M +8.66% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 42.3M +3.28M +8.42% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 41.2M +2.36M +6.06% Dec 31, 2016 10-K 2018-02-21
Q3 2016 40.1M +1.23M +3.17% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 39M +2.97M +8.25% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 39M +3.38M +9.49% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 38.9M +6.95M +21.8% Dec 31, 2015 10-K 2017-02-17
Q3 2015 38.8M +6.98M +21.9% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 36.1M +6.01M +20% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 35.6M +5.56M +18.5% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 31.9M +28.2M +748% Dec 31, 2014 10-K 2016-02-26
Q3 2014 31.8M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 30.1M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 30M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 3.77M Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.